Association study between genetic variations in Axin2 gene and lung cancer risk in North Indian population: A

Charu Bahl1, Siddharth Sharma1, Navneet Singh2

  • 11 Department of Biotechnology, Thapar University, Patiala, India.

Insights

Genetic variations in the Axin2 gene, specifically at sites 148 C>T and 1712+19 G>T, show a protective effect against lung cancer in North Indians. These Axin2 polymorphisms influence lung cancer susceptibility and may act as tumor suppressors.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • The Wnt signaling pathway is crucial in human carcinogenesis.
  • Axis inhibition protein 2 (Axin2) antagonizes the Wnt pathway and functions as a tumor suppressor.
  • Genetic variations in Axin2 may influence lung cancer susceptibility.

Purpose of the Study:

  • To investigate the association between seven polymorphic sites in the Axin2 gene and lung cancer risk in a North Indian population.
  • To identify specific Axin2 variants that confer protection or increase susceptibility to lung cancer.

Main Methods:

  • Genotyping of 608 subjects (303 cases, 305 controls) for seven Axin2 polymorphic sites using PCR-RFLP.
  • Association analysis using logistic regression to determine odds ratios and statistical significance.
  • Multivariate analysis including MDR and CART to evaluate gene-gene interactions.

Main Results:

  • Three Axin2 polymorphic sites (148 C>T, 1365 G>A, 1712+19 G>T) demonstrated a protective effect against lung cancer.
  • The Axin2 148 C>T variant (TT genotype) was significantly associated with squamous cell carcinoma (SQCC).
  • Axin2 1712+19 G>T heterozygous genotype (GT) showed decreased risk across all histological subtypes.
  • MDR and CART analyses identified significant interactions between Axin2 148, 2062, and 1712+19 SNPs in modulating lung cancer risk.

Conclusions:

  • Specific Axin2 gene polymorphisms (148 C>T, 1365 G>A, 1712+19 G>T) are associated with altered lung cancer risk in North Indians.
  • Axin2 variants, particularly 148 and 1712+19, play a significant role in modulating lung cancer susceptibility.
  • These findings highlight the potential of Axin2 as a biomarker for lung cancer risk assessment.

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...